- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Search trials
Studi clinici sponsorizzati da Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
Totale 32 risultati
-
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.Reclutamento
-
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.ReclutamentoNeoplasie | Neoplasie per tipo istologicoCina
-
Shanxi Province Cancer HospitalNovatim Immune Therapeutics (Zhejiang) Co., Ltd.Reclutamento
-
Shanxi Province Cancer HospitalNovatim Immune Therapeutics (Zhejiang) Co., Ltd.Reclutamento
-
Zhejiang UniversityCARsgen Therapeutics Co., Ltd.CompletatoCarcinoma epatocellulare avanzatoCina
-
Zhejiang UniversityCARsgen Therapeutics Co., Ltd.ReclutamentoCarcinoma epatocellulare avanzatoCina
-
Zhejiang UniversityOriCell Therapeutics Co., Ltd.Attivo, non reclutanteMieloma multiploCina
-
Zhejiang UniversityInnovative Cellular Therapeutics Co., Ltd.Sconosciuto
-
Changhai HospitalShanghai Ultra-T Immune Therapeutics Co. LTDNon ancora reclutamento
-
Zhejiang Genfleet Therapeutics Co., Ltd.ReclutamentoAvanzare il carcinoma polmonare non a piccole celluleSpagna, Italia, Grecia
-
Zhejiang Genfleet Therapeutics Co., Ltd.CompletatoTumore solido avanzatoCina, Australia
-
Zhejiang Genfleet Therapeutics Co., Ltd.Attivo, non reclutante
-
Zhejiang Genfleet Therapeutics Co., Ltd.ReclutamentoLinfoma a grandi cellule BCina
-
Zhejiang Genfleet Therapeutics Co., Ltd.Completato
-
Zhejiang Genfleet Therapeutics Co., Ltd.Completato
-
Zhejiang Genfleet Therapeutics Co., Ltd.ReclutamentoLinfoma a cellule T periferiche recidivato o refrattario (PTCL)Cina
-
Zhejiang Genfleet Therapeutics Co., Ltd.RitiratoClaudicazione intermittente | Malattia delle arterie perifericheStati Uniti
-
Zhejiang Genfleet Therapeutics Co., Ltd.Ritirato
-
Zhejiang UniversityHangzhou Cheetah Cell Therapeutics Co., LtdReclutamento
-
Carbiogene Therapeutics Co. Ltd.Zhejiang Provincial People's HospitalReclutamento
-
Zhejiang UniversityHangzhou Cheetah Cell Therapeutics Co., LtdReclutamento
-
Zhejiang UniversityShanghai First Song Therapeutics Co., LtdNon ancora reclutamentoLinfoma di Hodgkin | Linfoma anaplastico a grandi cellule | Linfoma angioimmunoblastico a cellule T | Linfoma diffuso a grandi cellule B | Linfoma della zona grigia | Linfoma a cellule NK/T | Linfoma periferico a cellule T, non specificato | Linfoma diffuso a grandi cellule mediastinico a cellule BCina
-
Shanxi Province Cancer HospitalShanghai Ultra-T Immune Therapeutics Co. LTDReclutamentoLeucemia linfocitica acuta, cellule BCina
-
Zhejiang Provincial People's HospitalHangzhou Neoantigen Therapeutics Co., Ltd.ReclutamentoCancro pancreatico resecabileCina
-
Zhejiang Provincial People's HospitalHangzhou Neoantigen Therapeutics Co., Ltd.CompletatoTumore del pancreas | Carcinoma pancreaticoCina
-
Weijia Fang, MDInnovative Cellular Therapeutics Co., Ltd.CompletatoTumori maligni degli organi digestiviCina
-
First Affiliated Hospital of Zhejiang UniversityCARsgen Therapeutics Co., Ltd.Attivo, non reclutanteMieloma multiplo refrattario o recidivatoCina
-
Second Affiliated Hospital, School of Medicine,...Carbiogene Therapeutics Co. Ltd.ReclutamentoMieloma multiplo recidivato o refrattarioCina
-
CARsgen Therapeutics Co., Ltd.RenJi Hospital; First Affiliated Hospital of Zhejiang UniversityCompletatoLinfoma non Hodgkin a cellule B refrattario | Linfoma non Hodgkin a cellule B recidivatoCina
-
Second Affiliated Hospital, School of Medicine,...Hangzhou Neoantigen Therapeutics Co., Ltd.ReclutamentoCancro esofageo resecabileCina
-
CARsgen Therapeutics Co., Ltd.RenJi Hospital; First Affiliated Hospital of Zhejiang University; NanJing PLA 81...CompletatoCarcinoma epatocellulareCina
-
CARsgen Therapeutics Co., Ltd.Xiangya Hospital of Central South University; Peking University People's Hospital e altri collaboratoriAttivo, non reclutante